Table 3.
Comparisons of histologic diagnoses n (%)
| LG | HG | EGC | NAL | Others | Total | Agreement | Discrepancy | |
| Between local clinic biopsy and repeat biopsy | ||||||||
| Adenoma | 11 (68.8) | 3 (18.8) | 0 (0) | 1 (6.3) | 1 (6.3) | 16 (100) | ||
| LG | 51 (83.6) | 4 (6.6) | 2 (3.3) | 4 (6.6) | 0 (0) | 61 (100) | 51 (83.6) | 10 (16.4) |
| HG | 11 (35.5) | 2 (6.5) | 16 (51.6) | 2 (6.5) | 0 (0) | 31 (100) | 2 (6.5) | 29 (93.5) |
| Total | 73 (67.6) | 9 (8.3) | 18 (16.7) | 7 (6.5) | 1 (0.9) | 108 (100) | 53 (57.6) | 39 (42.4) |
| Between local clinic and post procedure | ||||||||
| Adenoma | 60 (65.2) | 14 (15.2) | 6 (6.5) | 11 (12.0) | 1 (1.1) | 92 (100) | ||
| LG | 274 (71.7) | 42 (11.0) | 22 (5.8) | 43 (11.3) | 1 (0.3) | 382 (100) | 274 (71.7) | 108 (28.3) |
| HG | 22 (27.5) | 12 (15.0) | 44 (55.0) | 2 (2.5) | 0 (0) | 80 (100) | 12 (15.0) | 68 (85.0) |
| Total | 356 (64.3) | 68 (12.3) | 72 (13.0) | 56 (10.1) | 2 (0.4) | 554 (100) | 286 (61.9) | 176 (38.1) |
| Between repeat forcep biopsy and post procedure | ||||||||
| LG | 52 (71.2) | 1 (15.1) | 6 (8.2) | 3 (4.1) | 1 (1.4) | 73 (100) | 52 (71.2) | 21 (28.8) |
| HG | 3 (33.3) | 4 (44.4) | 2 (22.2) | 0 (0) | 0 (0) | 9 (100) | 4 (44.4) | 5 (45.6) |
| Adenocarcinoma | 0 (0) | 0 (0) | 17 (94.4) | 1 (5.6) | 0 (0) | 18 (100) | 17 (94.4) | 1 (5.6) |
| Benign lesion | 3 (42.9) | 0 (0) | 2 (28.6) | 2 (28.6) | 0 (0) | 7 (100) | 2 (28.6) | 5 (71.4) |
| Others | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 1 (100) | 1 (100) | 1 (100) | 0 (0) |
| Total | 58 (53.7) | 15 (13.9) | 27 (25.0) | 6 (5.6) | 2 (1.9) | 108 (100) | 76 (70.4) | 32 (29.6) |
LG: Low grade; HG: High grade; NAL: No adenomatous lesion; EGC: Early gastric cancer.